日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers

PEOPLE (NCT03447678) 是一项针对 PD-L1 阴性和低表达晚期非小细胞肺癌患者的一线 II 期帕博利珠单抗试验:临床结果及与循环免疫生物标志物的关联

Lo Russo, G; Sgambelluri, F; Prelaj, A; Galli, F; Manglaviti, S; Bottiglieri, A; Di Mauro, R M; Ferrara, R; Galli, G; Signorelli, D; De Toma, A; Occhipinti, M; Brambilla, M; Rulli, E; Triulzi, T; Torelli, T; Agnelli, L; Brich, S; Martinetti, A; Dumitrascu, A D; Torri, V; Pruneri, G; Fabbri, A; de Braud, F; Anichini, A; Proto, C; Ganzinelli, M; Mortarini, R; Garassino, M C

(PO-051) Catatonic with COVID-19

(PO-051)新冠肺炎引起的紧张性精神症

Nagaoka, Daiki; Tomoshige, Nanami; Ando, Shuntaro; Morita, Masaya; Kiyono, Tomoki; Kanata, Sho; Fujikawa, Shinya; Endo, Kaori; Yamasaki, Syudo; Fukuda, Masato; Nishida, Atsushi; Hiraiwa-Hasegawa, Mariko; Kasai, Kiyoto; Pacifici, S; Baglioni, V; Cammisa, L; Guerrini, D; Mancini, C; Mirabella, G; Terrinoni, A; Mouta, S; Fonseca Vaz, I; Jesus, B; Correia, J; Fontes, S; Adão, C; Rodrigues, DF; Sequeira, AS; Silva, B; Velosa, A; El Sayed, S; Gomaa, S; Eissa, A; Shohry, D; Kabil, A; Simas, J; Delgado, A; Guedes, R; Silveira, C; Soares, C; Esteve, RL; Sánchez-González, R; Campillo, M; Carrió, E; Jay, J; Kumar, V; Bidkhanian, P; Garrels, E; Segal, Y; Susaimanickam, B; Ramoz, N; Maussion, G; Clarke, J; Gorwood, P; Maffucci, A; Cesario, S; Mammarella, V; Colafrancesco, G; Ferrara, M; Raballo, A; Monducci, E; Petrykiv, S; Arts, M; De Jonge, L; Lee, S; Kim, J; Park, S-A; Kwan, Y; Choi, S-W; Orozco Aguirre, AL; Marín Valdovino, M; Ruíz Santos, MA; González Meléndez, AM; Petrykiv, S; Arts, M; De Jonge, L; Petrykiv, S; Arts, M; De Jonge, L; Bampi, A; Sorg, C; Brandl, F; Vita, G De; Terrinoni, A; Santo, F Di; Calderoni, D; Rainò, E; Anichini, A; Ferrara, M; Suárez-Gómez, M; Rodrigues, P; Gómez, A Suárez; Cammisa, L; Pacifici, S; Fegatelli, D Alunni; Calderoni, D; Fantini, F; Ferrara, M; Terrinoni, A; Gigliotti, F; Basile, C; Colaiori, M; Terrinoni, A; Ardizzone, I; Santo, F Di; Patel, Prit; Greenstein, Samuel

Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection

两例急性脑膜脑炎合并SARS-CoV-2感染患者

Bernard-Valnet, R; Pizzarotti, B; Anichini, A; Demars, Y; Russo, E; Schmidhauser, M; Cerutti-Sola, J; Rossetti, A O; Du Pasquier, R

Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation

更正:NFATc2 是黑色素瘤去分化的内在调节因子

Perotti, V; Baldassari, P; Molla, A; Vegetti, C; Bersani, I; Maurichi, A; Santinami, M; Anichini, A; Mortarini, R

Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma.

通过共同靶向人类黑色素瘤中的致癌和死亡受体通路,发挥协同抗肿瘤活性并抑制血管生成

Grazia G, Vegetti C, Benigni F, Penna I, Perotti V, Tassi E, Bersani I, Nicolini G, Canevari S, Carlo-Stella C, Gianni A M, Mortarini R, Anichini A

Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib

新型SMAC模拟物与TRAIL和硼替佐米联合使用可协同刺激黑色素瘤细胞死亡

Lecis, D; Drago, C; Manzoni, L; Seneci, P; Scolastico, C; Mastrangelo, E; Bolognesi, M; Anichini, A; Kashkar, H; Walczak, H; Delia, D

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions

转移性黑色素瘤患者外周T细胞群对细胞毒性T淋巴细胞(CTL)定义的黑色素细胞特异性抗原的扩增会影响肽特异性CTL的生成,但并不能克服转移性病灶中肿瘤逃避免疫监视的现象。

Anichini, A; Molla, A; Mortarini, R; Tragni, G; Bersani, I; Di Nicola, M; Gianni, A M; Pilotti, S; Dunbar, R; Cerundolo, V; Parmiani, G

High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition

原发性人类黑色素瘤中T细胞克隆扩增频率高。优势克隆型参与自体肿瘤识别。

Pisarra, P; Mortarini, R; Salvi, S; Anichini, A; Parmiani, G; Sensi, M

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

酪氨酸酶相关蛋白(TRP)2 mRNA中保留的内含子的翻译产生了一种新的细胞毒性T淋巴细胞(CTL)定义的、与人类黑色素瘤共有的抗原,该抗原在黑色素细胞谱系的正常细胞中不表达。

Lupetti, R; Pisarra, P; Verrecchia, A; Farina, C; Nicolini, G; Anichini, A; Bordignon, C; Sensi, M; Parmiani, G; Traversari, C

Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine

用半抗原修饰的自体肿瘤疫苗治疗后,人黑色素瘤转移灶中T淋巴细胞发生克隆扩增

Sensi, M; Farina, C; Maccalli, C; Lupetti, R; Nicolini, G; Anichini, A; Parmiani, G; Berd, D